Cinryze IV (C1 esterase inhibitor [human] IV) / Takeda  >>  Phase 1
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Cinryze IV (C1 esterase inhibitor [human] IV) / Takeda
NCT01759602: C1-esterase Inhibitor (Cinryze) for Acute Treatment of Neuromyelitis Optica Exacerbation

Completed
1b
10
US
C1-esterase inhibitor (Cinryze), Cinryze
Michael Levy, ViroPharma
Neuromyelitis Optica
11/13
11/13
NCT02663687: Phase 1 Study to Assess the Safety, Tolerability, and Pharmacokinetics of Recombinant Human C1 Esterase Inhibitor in Healthy Adult Subjects

Completed
1
48
US
Recombinant human C1 esterase inhibitor, SHP623, Placebo
Shire
Hereditary Angioedema (HAE)
12/16
12/16
NCT02435732: CINRYZE as a Donor Pre-treatment Strategy in Kidney Recipients of KDPI>60%

Not yet recruiting
1
72
NA
Placebo saline solution, Heparin, CINRYZE, C1INH
University of Wisconsin, Madison, Shire
Kidney Failure
05/21
05/22

Download Options